Literature DB >> 22528682

Neuroprotective roles of the P2Y(2) receptor.

Gary A Weisman1, Deepa Ajit, Richard Garrad, Troy S Peterson, Lucas T Woods, Christina Thebeau, Jean M Camden, Laurie Erb.   

Abstract

Purinergic signaling plays a unique role in the brain by integrating neuronal and glial cellular circuits. The metabotropic P1 adenosine receptors and P2Y nucleotide receptors and ionotropic P2X receptors control numerous physiological functions of neuronal and glial cells and have been implicated in a wide variety of neuropathologies. Emerging research suggests that purinergic receptor interactions between cells of the central nervous system (CNS) have relevance in the prevention and attenuation of neurodegenerative diseases resulting from chronic inflammation. CNS responses to chronic inflammation are largely dependent on interactions between different cell types (i.e., neurons and glia) and activation of signaling molecules including P2X and P2Y receptors. Whereas numerous P2 receptors contribute to functions of the CNS, the P2Y(2) receptor is believed to play an important role in neuroprotection under inflammatory conditions. While acute inflammation is necessary for tissue repair due to injury, chronic inflammation contributes to neurodegeneration in Alzheimer's disease and occurs when glial cells undergo prolonged activation resulting in extended release of proinflammatory cytokines and nucleotides. This review describes cell-specific and tissue-integrated functions of P2 receptors in the CNS with an emphasis on P2Y(2) receptor signaling pathways in neurons, glia, and endothelium and their role in neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528682      PMCID: PMC3360094          DOI: 10.1007/s11302-012-9307-6

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  277 in total

1.  Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.

Authors:  J Priller; A Flügel; T Wehner; M Boentert; C A Haas; M Prinz; F Fernández-Klett; K Prass; I Bechmann; B A de Boer; M Frotscher; G W Kreutzberg; D A Persons; U Dirnagl
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

Review 2.  The birth and postnatal development of purinergic signalling.

Authors:  G Burnstock; B B Fredholm; R A North; A Verkhratsky
Journal:  Acta Physiol (Oxf)       Date:  2010-03-24       Impact factor: 6.311

Review 3.  Microglia and neuroprotection: implications for Alzheimer's disease.

Authors:  Wolfgang J Streit
Journal:  Brain Res Brain Res Rev       Date:  2005-01-15

4.  Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid.

Authors:  Rodrigo Alarcón; Carolina Fuenzalida; Marcos Santibáñez; Rommy von Bernhardi
Journal:  J Biol Chem       Date:  2005-06-29       Impact factor: 5.157

5.  P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing.

Authors:  Jean M Camden; Ann M Schrader; Ryan E Camden; Fernando A González; Laurie Erb; Cheikh I Seye; Gary A Weisman
Journal:  J Biol Chem       Date:  2005-03-18       Impact factor: 5.157

6.  The P2Y2 nucleotide receptor requires interaction with alpha v integrins to access and activate G12.

Authors:  Zhongji Liao; Cheikh I Seye; Gary A Weisman; Laurie Erb
Journal:  J Cell Sci       Date:  2007-05-01       Impact factor: 5.285

7.  P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice.

Authors:  May Nour; Alexander B Quiambao; Ward M Peterson; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-10       Impact factor: 4.799

8.  Activation of P2X(7) receptors stimulates the expression of P2Y(2) receptor mRNA in astrocytes cultured from rat brain.

Authors:  I D'Alimonte; R Ciccarelli; P Di Iorio; E Nargi; S Buccella; P Giuliani; M P Rathbone; S Jiang; F Caciagli; P Ballerini
Journal:  Int J Immunopathol Pharmacol       Date:  2007 Apr-Jun       Impact factor: 3.219

Review 9.  P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system.

Authors:  Greg James; Arthur M Butt
Journal:  Eur J Pharmacol       Date:  2002-07-05       Impact factor: 4.432

10.  Altered neurogenesis in Alzheimer's disease.

Authors:  Iryna Ziabreva; Elaine Perry; Robert Perry; Stephen L Minger; Antigoni Ekonomou; Stefan Przyborski; Clive Ballard
Journal:  J Psychosom Res       Date:  2006-09       Impact factor: 3.006

View more
  17 in total

Review 1.  Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.

Authors:  Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2015-11-06       Impact factor: 3.765

Review 2.  Purinergic receptors as potential therapeutic targets in Alzheimer's disease.

Authors:  Lucas T Woods; Deepa Ajit; Jean M Camden; Laurie Erb; Gary A Weisman
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

3.  Erythropoietin increases neuronal NDPKA expression, and NDPKA up-regulation as well as exogenous application protects cortical neurons from in vitro ischemia-related insults.

Authors:  Jonathan Teoh; Sherif Boulos; Joanne Chieng; Neville W Knuckey; Bruno P Meloni
Journal:  Cell Mol Neurobiol       Date:  2014-01-07       Impact factor: 5.046

4.  Extracellular Adenosine Triphosphate Binding to P2Y1 Receptors Prevents Glutamate-Induced Excitotoxicity: Involvement of Erk1/2 Signaling Pathway to Suppress Autophagy.

Authors:  Yiping Xiong; Duanyang Zhou; Kai Zheng; Wenchuan Bi; Yun Dong
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

5.  Loss of P2Y₂ nucleotide receptors enhances early pathology in the TgCRND8 mouse model of Alzheimer's disease.

Authors:  Deepa Ajit; Lucas T Woods; Jean M Camden; Christina N Thebeau; Farid G El-Sayed; Glen W Greeson; Laurie Erb; Michael J Petris; Douglas C Miller; Grace Y Sun; Gary A Weisman
Journal:  Mol Neurobiol       Date:  2013-11-06       Impact factor: 5.590

6.  Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells.

Authors:  Namyr A Martinez; Alondra M Ayala; Magdiel Martinez; Freddyson J Martinez-Rivera; Jorge D Miranda; Walter I Silva
Journal:  J Biol Chem       Date:  2016-04-18       Impact factor: 5.157

7.  Up-regulation and activation of the P2Y(2) nucleotide receptor mediate neurite extension in IL-1β-treated mouse primary cortical neurons.

Authors:  Troy S Peterson; Christina N Thebeau; Deepa Ajit; Jean M Camden; Lucas T Woods; W Gibson Wood; Michael J Petris; Grace Y Sun; Laurie Erb; Gary A Weisman
Journal:  J Neurochem       Date:  2013-04-25       Impact factor: 5.372

8.  Development of Alzheimer's Disease Progressively Alters Sex-Dependent KCa and Sex-Independent KIR Channel Function in Cerebrovascular Endothelium.

Authors:  Md A Hakim; Erik J Behringer
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

9.  Uridine 5'-triphosphate promotes in vitro Schwannoma cell migration through matrix metalloproteinase-2 activation.

Authors:  Aloa Lamarca; Alejandro Gella; Tania Martiañez; Mònica Segura; Joana Figueiro-Silva; Carmen Grijota-Martinez; Ramón Trullas; Núria Casals
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

Review 10.  P2X and P2Y receptors—role in the pathophysiology of the nervous system.

Authors:  Kamila Puchałowicz; Maciej Tarnowski; Irena Baranowska-Bosiacka; Dariusz Chlubek; Violetta Dziedziejko
Journal:  Int J Mol Sci       Date:  2014-12-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.